Indivior Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Indivior's estimated annual revenue is currently $303.3M per year.(i)
  • Indivior's estimated revenue per employee is $201,000

Employee Data

  • Indivior has 1509 Employees.(i)
  • Indivior grew their employee count by 10% last year.

Indivior's People

NameTitleEmail/Phone
1
Global VP Strategic MarketingReveal Email/Phone
2
CEOReveal Email/Phone
3
Sr. VP, US SalesReveal Email/Phone
4
Chief Staff and VP Corporate DevelopmentReveal Email/Phone
5
Head Manufacturing and SupplyReveal Email/Phone
6
SVP Europe, Canada and MEA operationsReveal Email/Phone
7
Head Procurement Business Process and IntelligenceReveal Email/Phone
8
Head QA & QC, FCPReveal Email/Phone
9
VP Global Supply ChainReveal Email/Phone
10
Head Quality Operations Asia-PacificReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.9M7925%$210MN/A
#2
$30.2M182N/AN/AN/A
#3
$6.6M336%N/AN/A
#4
$7.8M39-39%N/AN/A
#5
$4.8M244%N/AN/A
#6
$12.5M627%N/AN/A
#7
$22.1M1107%N/AN/A
#8
$11.7M58-9%N/AN/A
#9
$5.8M29-12%N/AN/A
#10
$42.4M211N/AN/AN/A
Add Company

What Is Indivior?

As a world leader in addiction treatment, we envision a day in which all patients around the world will have unrestricted access to quality treatments and services for the chronic relapsing conditions and co-morbidities of addiction. Our name is iconic of the individual patient's journey to reclaim their life from the disease of addiction and our endeavor to address patient's unmet needs. Over the past 20 years, we have built an organization with a unique business approach focused on humanizing people suffering from addiction, empowering patients and transforming addiction from a global human crisis to a recognized and treated chronic disease worldwide. Indivior's people have a passion to help patients and enable those who can treat them. As a result, we continue to pioneer innovative and accessible therapies for: - Opioid use disorder - Alcohol use disorder - Rescue Medications - Co-morbidities of addiction/schizophrenia Our guiding principles foster a corporate culture of trust, innovation, and a pioneering spirit to: - Focus on patient needs to drive decisions - Seek the wisdom of the team - Believe that people's actions are well intended - Care enough to coach - See it, own it, make it happen - Demonstrate honesty and integrity at all times Opioid use disorder, Alcohol use disorder, Rescue Medications, Schizophrenia

keywords:N/A

N/A

Total Funding

1509

Number of Employees

$303.3M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Indivior News

2022-04-20 - Indivior's 1Q Pretax Profit Fell; To Launch $100 Mln Buyback Program

By Sabela Ojea. Indivior PLC on Thursday reported a decline in pretax profit and a rise in net revenue for the first quarter, and said it is...

2022-04-20 - Indivior Announces Q1 2022 Financial Results

SLOUGH, U.K. and RICHMOND, Va., April 28, 2022 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced its financial results for the period...

2022-04-20 - Indivior set to meet full-year guidance; announces buyback

Indivior said its guidance for 2022 remains unchanged. Previously, the company said expects its 2022 revenue to be between USD840 million to...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35M152510%N/A
#2
$75M1528N/AN/A
#3
$319.7M1575N/AN/A
#4
$752.1M16074%N/A
#5
$672.7M165714%N/A